Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Megan E Barra"'
Publikováno v:
Neurotherapeutics, Vol 21, Iss 4, Pp e00374- (2024)
Severe brain injury impairs consciousness by disrupting a broad spectrum of neurotransmitter systems. Emerging evidence suggests that pharmacologic modulation of specific neurotransmitter systems, such as dopamine, promotes recovery of consciousness.
Externí odkaz:
https://doaj.org/article/aebae8dae8d846298cb7ca790421e0a7
Autor:
Megan E. Barra, Rachel Forman, Bianca Long‐Fazio, Alexander E. Merkler, M. E. Gurol, Saef Izzy, Richa Sharma
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 10 (2024)
Background Anticoagulation in patients with intracranial hemorrhage (ICH) and mechanical heart valves is often held for risk of ICH expansion; however, there exists a competing risk of acute ischemic stroke (AIS). Optimal timing to resume anticoagula
Externí odkaz:
https://doaj.org/article/adeb1ccb2cbe43eba424194b2a11025d
Autor:
Wang Pong Chan, BS, BA, Brenton R. Prescott, MS, Megan E. Barra, PharmD, David Y. Chung, MD, PhD, Ivy S. Kim, MPH, Hanife Saglam, MD, Meghan R. Hutch, BS, Min Shin, PhD, Sahar F. Zafar, MD, MBBS, Emelia J. Benjamin, MD, ScM, Stelios M. Smirnakis, MD, PhD, Josée Dupuis, PhD, David M. Greer, MD, MA, Charlene J. Ong, MD, MPHS
Publikováno v:
Critical Care Explorations, Vol 4, Iss 5, p e0691 (2022)
OBJECTIVES:. In critically ill patients with neurologic disease, pupil examination abnormalities can signify evolving intracranial pathology. Analgesic and sedative medications (analgosedatives) target pupillary pathways, but it remains unknown how a
Externí odkaz:
https://doaj.org/article/f9a5367604aa45109d02f61036214a11
Autor:
Sherif Hanafy Mahmoud, Fatma R. Hefny, Nicholas G. Panos, Laura Delucilla, Zinquon Ngan, Marc M. Perreault, Leslie A. Hamilton, A. Shaun Rowe, Pamela L. Buschur, Jocelyn Owusu‐Guha, Sulaiman Almohaish, Melissa Sandler, Michael J. Armahizer, Megan E. Barra, Aaron M. Cook, Colleen A. Barthol, Trager D. Hintze, Anna Cantin, Jessica Traeger, Joseph R. Blunck, Justin Shewmaker, Sarah V. Burgess, Kristin Kaupp, Caitlin S. Brown, Sarah L. Clark, Erin D. Wieruszewski, Eljim P. Tesoro, Abdalla A. Ammar, Mahmoud A. Ammar, Mandy J. Binning, Stanislav Naydin, Neal Fox, David M. Peters, Leana N. Mahmoud, Shaun P. Keegan, Gretchen M. Brophy
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 43:279-290
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00a58b8df4e86cad2caa5e76bb91c83e
https://doi.org/10.1002/phar.2791
https://doi.org/10.1002/phar.2791
Autor:
Megan E. Barra, Andrew J. Webb, Russel J. Roberts, Marjorie Ross, Robert Hallisey, Paul Szumita, Amanda C. Guidon
Publikováno v:
Muscle & Nerve. 67:284-290
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d41e62c462dddb13a7a908c52d8cbc1
https://doi.org/10.1002/mus.27790
https://doi.org/10.1002/mus.27790
Autor:
Megan E. Barra PharmD, BCPS, BCCCP, Steven K. Feske MD, Katelyn W. Sylvester PharmD, BCPS, Charlene Ong MD, MPHS, Sarah E. Culbreth PharmD, BCPS, Patricia Krause PharmD, BCPS, Galen V. Henderson MD, Eva Rybak PharmD, BCPS
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 26 (2020)
In patients with ischemic stroke who receive systemic recombinant tissue plasminogen activator (rt-PA), the risk of secondary hemorrhage is 1-7%. Fibrinogen supplementation with cryoprecipitate is recommended in patients with rt-PA-associated symptom
Externí odkaz:
https://doaj.org/article/982e1705b0f84bb58a2f011c5b72978f
Publikováno v:
Neurocritical Care. 38:312-319
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::444bbd2ba7318b1c2e01ba1749b3a35e
https://doi.org/10.1007/s12028-022-01604-1
https://doi.org/10.1007/s12028-022-01604-1
Publikováno v:
Seminars in Neurology. 42:335-347
Pharmacologic interventions are commonly used to support rehabilitation efforts of patients with disorders of consciousness (DoC). The 2018 practice guidelines recommend amantadine in adults with traumatic DoC to promote functional recovery, though s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d86d0a2bdf2eda7ba0fd528730485be2
https://doi.org/10.1055/s-0042-1755271
https://doi.org/10.1055/s-0042-1755271
Autor:
Greer Waldrop, Seyed A. Safavynia, Megan E. Barra, Sachin Agarwal, David A. Berlin, Amelia K Boehme, Daniel Brodie, Jacky M. Choi, Kevin Doyle, Joseph J. Fins, Wolfgang Ganglberger, Katherine Hoffman, Aaron M. Mittel, David Roh, Shibani S. Mukerji, Caroline Der Nigoghossian, Soojin Park, Edward J. Schenck, John Salazar‐Schicchi, Qi Shen, Evan Sholle, Angela G. Velazquez, Maria C. Walline, M. Brandon Westover, Emery N. Brown, Jonathan Victor, Brian L. Edlow, Nicholas D. Schiff, Jan Claassen
Publikováno v:
Annals of Neurology. 91:740-755
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::603f268f72bb16e6535ea856c2ee193a
https://doi.org/10.1002/ana.26342
https://doi.org/10.1002/ana.26342
Autor:
Megan E Barra, William R. Sanders, David Fischer, Pamela W. Schaefer, Yelena G. Bodien, Andrea S. Foulkes, Otto Rapalino, Brian L. Edlow, Samuel B. Snider
Publikováno v:
Neurology. 98:e315-e325
Background and ObjectivesIn patients with severe coronavirus disease 2019 (COVID-19), disorders of consciousness (DoC) have emerged as a serious complication. The prognosis and pathophysiology of COVID-DoC remain unclear, complicating decisions about
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f7a2aee08bb6b11848942798fb03668
https://doi.org/10.1212/wnl.0000000000013067
https://doi.org/10.1212/wnl.0000000000013067